Commodore Capital Lp - Sep 30, 2025 SCHEDULE 13G/A Report for Viridian Therapeutics, Inc.\DE Common Stock, $0.01 par value (VRDN)

Filing Manager: Commodore Capital LP
Reporting Manager: Commodore Capital LP
Security: Viridian Therapeutics, Inc.\DE Common Stock, $0.01 par value
Symbol: VRDN
Shares outstanding: 82.1M shares
Disclosed Ownership: 3.2M shares
Ownership: 3.9%
Form type: SCHEDULE 13G/A
Date filed: 11/14/2025, 05:17 PM
Date of event: Sep 30, 2025
Previous filing: Apr 11, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Commodore Capital LP	3.9%	3.2M	0	3.2M	Michael Kramarz	Managing Partner
Commodore Capital Master LP	3.9%	3.2M	0	3.2M	Michael Kramarz	Managing Partner